Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol PR vs Oxycodone/Naloxone PR in Severe Chronic Low Back Pain
NCT01838616Phase 4Completed
- Sponsor
- Grünenthal GmbH
- Start
- Apr 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of tapentadol in chronic low back pain (CLBP), sponsored by Grünenthal GmbH. Started Apr 2013; status: completed.
02
Drugs
tapentadol
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT01838616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01838616.